Works by Jiujie Cui

Results: 23

Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma.

Published in:

Cancer Biology & Medicine, 2020, v. 17, n. 4, p. 953, doi. 10.20892/j.issn.2095-3941.2019.0427

By:

Ting Han;
Meng Zhuo;
Cuncun Yuan;
Xiuying Xiao;
Jiujie Cui;
Guangrong Qin;
Liwei Wang;
Feng Jiao

Publication type:

Article

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study.

Published in:

2021

By:

Zou, Lu;
Li, Xuechuan;
Wu, Xiangsong;
Cui, Jiujie;
Cui, Xuya;
Song, Xiaoling;
Ren, Tai;
Han, Xusheng;
Zhu, Yidi;
Li, Huaifeng;
Wu, Wenguang;
Wang, Xu'an;
Gong, Wei;
Wang, Liwei;
Li, Maolan;
Lau, Wan Yee;
Liu, Yingbin

Publication type:

journal article

RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.

Published in:

2020

By:

Yang, Haiyan;
Hu, Jiong;
Chen, Jingde;
Chen, Zhiqin;
Jiao, Feng;
Cui, Jiujie;
Quan, Ming;
Wang, Liwei

Publication type:

journal article

Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype.

Published in:

Medical Oncology, 2015, v. 32, n. 5, p. 1, doi. 10.1007/s12032-015-0589-8

By:

Cui, Jiujie;
Quan, Ming;
Jiang, Weihua;
Hu, Hai;
Jiao, Feng;
Li, Ning;
Jin, Ziliang;
Wang, Lei;
Wang, Yu;
Wang, Liwei

Publication type:

Article

CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.

Published in:

Cell Death & Disease, 2021, v. 12, n. 10, p. 1, doi. 10.1038/s41419-021-04148-y

By:

Lin, Xiaolin;
Han, Ting;
Xia, Qing;
Cui, Jiujie;
Zhuo, Meng;
Liang, Yiyi;
Su, Wenyu;
Wang, Lisha;
Wang, Liwei;
Liu, Zebing;
Xiao, Xiuying

Publication type:

Article

Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china.

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2021, v. 21, n. 4, p. 691, doi. 10.1080/14737167.2020.1812386

By:

Cui, Jiujie;
Zhang, Xiaochen;
Qu, Shuli;
Wang, Liwei

Publication type:

Article

The roles of FOXM1 in pancreatic stem cells and carcinogenesis.

Published in:

Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-159

By:

Ming Quan;
Peipei Wang;
Jiujie Cui;
Yong Gao;
Keping Xie

Publication type:

Article

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response.

Published in:

Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00271-4

By:

Wang, Yu;
Liang, Yiyi;
Xu, Haiyan;
Zhang, Xiao;
Mao, Tiebo;
Cui, Jiujie;
Yao, Jiayu;
Wang, Yongchao;
Jiao, Feng;
Xiao, Xiuying;
Hu, Jiong;
Xia, Qing;
Zhang, Xiaofei;
Wang, Xujun;
Sun, Yongwei;
Fu, Deliang;
Shen, Lei;
Xu, Xiaojiang;
Xue, Jing;
Wang, Liwei

Publication type:

Article

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.

Published in:

Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-01965-5

By:

Ge, Weiyu;
Wang, Yanling;
Quan, Ming;
Mao, Tiebo;
Bischof, Evelyne Y.;
Xu, Haiyan;
Zhang, Xiaofei;
Li, Shumin;
Yue, Ming;
Ma, Jingyu;
Yang, Haiyan;
Wang, Lei;
Yu, Zhengyuan;
Wang, Liwei;
Cui, Jiujie

Publication type:

Article

Efficacy of olanzapine for quality of life improvement among patients with malignant tumor: A systematic review.

Published in:

Cancer Reports, 2019, v. 2, n. 4, p. N.PAG, doi. 10.1002/cnr2.1167

By:

Ji, Mengting;
Cui, Jiujie;
Xi, Huiqin;
Yang, Yan;
Wang, Liwei

Publication type:

Article

Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer.

Published in:

Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1135-0

By:

Jiao, Feng;
Han, Ting;
Yuan, Cuncun;
Liang, Yiyi;
Cui, Jiujie;
Zhuo, Meng;
Wang, Liwei

Publication type:

Article

Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-019-1489-0

By:

Quan, Ming;
Chen, Zhiqin;
Jiao, Feng;
Xiao, Xiuying;
Xia, Qing;
Chen, Jingde;
Chao, Qian;
Li, Yandong;
Gao, Yong;
Yang, Haiyan;
Wang, Liwei;
Cui, Jiujie

Publication type:

Article

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 156, doi. 10.3390/ijms24010156

By:

Ge, Weiyu;
Yue, Ming;
Wang, Yanling;
Wang, Yongchao;
Xue, Shengbai;
Shentu, Daiyuan;
Mao, Tiebo;
Zhang, Xiaofei;
Xu, Haiyan;
Li, Shumin;
Ma, Jingyu;
Wang, Liwei;
Cui, Jiujie

Publication type:

Article

ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 380, doi. 10.1007/s00259-023-06454-3

By:

Huang, Wei;
Liang, Chenyi;
Zhang, You;
Zhang, Di;
An, Shuxian;
Wu, Qianyun;
Li, Jiajin;
Zhao, Haitao;
Wang, Cheng;
Cui, Jiujie;
Bao, Zhouzhou;
Huang, Gang;
Wei, Weijun;
Liu, Jianjun

Publication type:

Article

Cover Image, Volume 42, Issue 1.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. ii, doi. 10.1002/cac2.12269

By:

Zhang, Xiaofei;
Mao, Tiebo;
Zhang, Bei;
Xu, Haiyan;
Cui, Jiujie;
Jiao, Feng;
Chen, Dongqin;
Wang, Yu;
Hu, Jiong;
Xia, Qing;
Li, Shumin;
Yue, Ming;
Ma, Jingyu;
Yao, Jiayu;
Wang, Yongchao;
Zhang, Xiao;
Chen, Shiqing;
Bai, Yuezong;
Wang, Yuexiang;
Zhang, Xuebin

Publication type:

Article

Characterization of DNA damage response deficiency in pancreatic cancer patients from China.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 70, doi. 10.1002/cac2.12238

By:

Zhang, Xiaofei;
Mao, Tiebo;
Zhang, Bei;
Xu, Haiyan;
Cui, Jiujie;
Jiao, Feng;
Chen, Dongqin;
Wang, Yu;
Hu, Jiong;
Xia, Qing;
Li, Shumin;
Yue, Ming;
Ma, Jingyu;
Yao, Jiayu;
Wang, Yongchao;
Zhang, Xiao;
Chen, Shiqing;
Bai, Yuezong;
Wang, Yuexiang;
Zhang, Xuebin

Publication type:

Article

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial.

Published in:

Signal Transduction & Targeted Therapy, 2024, p. 1, doi. 10.1038/s41392-024-01948-4

By:

Cui, Jiujie;
Qin, Shukui;
Zhou, Yuhong;
Zhang, Shuang;
Sun, Xiaofeng;
Zhang, Mingjun;
Cui, Jiuwei;
Fang, Weijia;
Gu, Kangsheng;
Li, Zhihua;
Wang, Jufeng;
Chen, Xiaobing;
Yao, Jun;
Zhou, Jun;
Wang, Gang;
Bai, Yuxian;
Xiao, Juxiang;
Qiu, Wensheng;
Wang, Bangmao;
Xia, Tao

Publication type:

Article

Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma.

Published in:

EMBO Molecular Medicine, 2024, v. 16, n. 5, p. 1115, doi. 10.1038/s44321-024-00060-y

By:

Wang, Simin;
Xiong, Yangjie;
Luo, Yuxiang;
Shen, Yanying;
Zhang, Fengrui;
Lan, Haoqi;
Pang, Yuzhi;
Wang, Xiaofang;
Li, Xiaoqi;
Zheng, Xufen;
Lu, Xiaojing;
Liu, Xiaoxiao;
Cheng, Yumei;
Wu, Tanwen;
Dong, Yue;
Lu, Yuan;
Cui, Jiujie;
Jia, Xiaona;
Yang, Sheng;
Wang, Liwei

Publication type:

Article

A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.

Published in:

2018

By:

Zhuo, Meng;
Yuan, Cuncun;
Han, Ting;
Cui, Jiujie;
Jiao, Feng;
Wang, Liwei

Publication type:

journal article

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890715

By:

Ge, Weiyu;
Ma, Jingyu;
Mao, Tiebo;
Xu, Haiyan;
Zhang, Xiaofei;
Li, Shumin;
Wang, Yongchao;
Yao, Jiayu;
Yue, Ming;
Jiao, Feng;
Wang, Yu;
Zhuo, Meng;
Han, Ting;
Hu, Jiong;
Zhang, Xiao;
Cui, Jiujie;
Wang, Liwei

Publication type:

Article

Association of a novel point mutation in MSH2 gene with familial multiple primary cancers.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0523-y

By:

Hai Hu;
Hong Li;
Feng Jiao;
Ting Han;
Meng Zhuo;
Jiujie Cui;
Yixue Li;
Liwei Wang

Publication type:

Article

Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.

Published in:

IET Systems Biology (Wiley-Blackwell), 2023, v. 17, n. 4, p. 174, doi. 10.1049/syb2.12068

By:

Wang, Yanling;
Ge, Weiyu;
Xue, Shengbai;
Cui, Jiujie;
Zhang, Xiaofei;
Mao, Tiebo;
Xu, Haiyan;
Li, Shumin;
Ma, Jingyu;
Yue, Ming;
Shentu, Daiyuan;
Wang, Liwei

Publication type:

Article

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma.

Published in:

2021

By:

Cui, Jiujie;
Yang, Haiyan;
Liu, Jue;
Chen, Donghui;
Hu, Jiong;
Zhang, Haiyan;
Wang, Yu;
Han, Ting;
Mao, Tiebo;
Jiao, Feng;
Biskup, Ewelina;
Pan, Yaotian;
Liu, Min;
Wang, Liwei

Publication type:

journal article